Elisa Agostinetto· @ElisaAgostinett · X·· 1 天前评分70
正文 · 机器翻译
在 #ESMO26 晚期 #breastcancer 快速口头报告环节
@KalinskyKevin 介绍了 postMONARCH 的研究结果
Abema + fulvestrant 在经 CDK4-6i 治疗后进展（PD）的 aBC 患者中显示出 OS 数值上升，但未达到统计学显著性 ⬆️
PFS 有小幅改善
@OncoAlert
125 浏览 · 5 赞 · 4 转发 · 1 回复
会议摘要
1RO按 Rapid oral 1: Breast cancer, advanced stage 对上
Overall survival from the phase 3 postMONARCH trial of abemaciclib + fulvestrant vs placebo + fulvestrant for HR+, HER2- advanced breast cancer following progression on a prior CDK4/6 inhibitor + endocrine therapy
https://esmocongress.esmo.org帖内回复
- Elisa Agostinetto@ElisaAgostinett
Simultaneous publication in @Annals_Oncology ‼️ https://www.annalsofoncology.org/article/S0923-7534%2826%2908075-0/fulltext @OncoAlert @myESMO
来源：Elisa Agostinetto · x.com